Adverse events12

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 12 of 12

Type	Event	Organ system	Group	Affected	At risk	Events
other	Shortness of Breath	Cardiac disorders	I- Diltiazem	6	18	9
other	Shortness of Breath	Cardiac disorders	II- Placebo	1	20	1
other	Lightheadeness	Cardiac disorders	I- Diltiazem	3	18	5
other	Lightheadeness	Cardiac disorders	II- Placebo	5	20	6
other	Nausea/GI distress	Gastrointestinal disorders	I- Diltiazem	1	18	1
other	Nausea/GI distress	Gastrointestinal disorders	II- Placebo	4	20	4
other	Fatigue	General disorders	I- Diltiazem	1	18	1
other	Fatigue	General disorders	II- Placebo	2	20	2
other	Headache	Nervous system disorders	I- Diltiazem	0	18	0
other	Headache	Nervous system disorders	II- Placebo	1	20	2
other	Chest Pain	Cardiac disorders	I- Diltiazem	3	18	3
other	Chest Pain	Cardiac disorders	II- Placebo	1	20	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00319982/events